LONDON (AP) – Major COVID-19 vaccines show a high level of protection, with British officials cautious – and they cautiously straining – optimistic that life could begin to return to normal in early April.
Before regulators approve a single vaccine, the UK and European countries are rapidly moving to organize the distribution and delivery systems needed for the inclusion of millions of citizens.
“If we can roll it on a good sauce … then with favorable winds, this is a complete fantasy, but we should be able to inoculate, I believe the evidence I see, most people need by Easter The highest security, ”Prime Minister Boris Johnson said Monday, adding that vaccine manufacturers had released encouraging results in recent weeks. “It will make a very significant difference to where we are at the moment.”
More than 55,000 people have been killed in Europe in connection with the Covid-19, the deadliest outbreak in Europe. The epidemic has prevented families from meeting, laid off 750,000 people and disrupted businesses that were forced to close as authorities tried to contain the spread. England’s second national lockdown will end on 2 December, but many restrictions will remain in place.
The British government has agreed to purchase 355 million doses of the vaccine from seven different manufacturers, as it prepares to vaccinate as many as 67 million people in the country as much as possible. Governments around the world are entering into agreements with multiple developers to ensure that they eventually lock up the delivery of products approved by regulators.
The National Health Service is planning to give 88.5 million vaccine doses in England. According to a document dated 13 November, Scotland, Wales and Northern Ireland are developing their own plans under the UK’s distorted administration system.
The vaccine will first be administered by health care workers and nursing home residents, then by the elderly, starting with people over 80, according to the document, first reported by the London-based Health Service Journal. People under the age of 65 with underlying medical conditions will be next, then healthy people 50 to 65 and finally everyone aged 18 and over.
Most injections will be delivered to about 1,000 community vaccination centers, while a third will be delivered to 40 to 50 “large-scale mass vaccination centers,” stadiums, conference centers, and similar venues, the document said.
The NHSA confirmed that the document is genuine but said the details and target date are always changing as the vaccination program progresses.
“Britain has a well-developed medical infrastructure that can be used to deliver vaccines,” said Mark Jeet, a vaccine epidemiologist at the London School of Hygiene and Tropical Medicine.
But this effort would be in stark contrast to standardized vaccination programs that target individuals one at a time.
The challenge now is to deliver the largest vaccine program in living memory in the UK and other countries around the world, Jit said. “We don’t just vaccinate babies or pregnant women like many child immunization programs … we are trying to vaccinate the whole UK population. And we’re trying to do it very quickly. ”
As other European countries prepare, there are companies that will be crucial to the rollout.
Germany’s Binder, for example, which makes special cooling devices for laboratories, has increased production of refrigerated containers needed to transport some vaccines under development. Binder is building a unit that will reach the extreme-cold temperatures needed to send Pfizer’s vaccine.
The German government has asked regional authorities to set up special vaccination centers by mid-December. France, meanwhile, has reserved 90 million vaccine doses, but has not yet announced its plans for mass vaccinations. A government spokesman said last week that officials were working to identify locations for vaccination centers, select companies to carry vaccines and set rules for shipping and storage.
In Spain, health workers will get priority, as do residents of elder care homes. Spain is expected to vaccinate about 25 million people in the first phase between January and March and cover the most vulnerable population during the middle year. 13,000 public health centers will be vaccinated.
But sticking the syringe in people’s hands is just the last part of the enormous logistical challenge that the global mass vaccination campaign will do.
First, drug makers must increase production, so there is enough supply for billions of people to be vaccinated over the months. They then have to store the distribution barrier such as some products at minus-70 ડિગ્રી C (minus-94 Fahrenheit). Eventually, they will need to operate a complex supply chain, designed by car-manufacturers to keep their factories humming.
“Basically, because of the volumes and everything else, it will be the challenge of the century,” said Richard Wilding, a professor of supply chain strategy at Krutfield School Management. “It’s just full scale.”
Vaccines from three drug manufacturers are considered leading candidates. Pfizer and Moderna have released preliminary data showing that their vaccine was about 95% effective. AstraZeneca on Monday reported the interim results of developing its vaccine with vaccine Xford researchers which was also encouraging. Dozens of other vaccines are under development, including projects in China And Russia.
Chris Whitty, England’s chief medical officer, said Britain and other Northern Hemisphere countries would also experience the weather. Respiratory virus infections usually slow down during the warmer months.
“The virus will disappear, but it will become less and more dangerous to society.”
But Johnson, who credited NHS nurses for saving their lives after being hospitalized in COVID-19 earlier this year, warned that sanctions would continue for months and that Christmas celebrations would be reduced this year.
“We can hear cavalry drumming hoops coming up the hillside, but they’re not here yet.” Johnson said.
Associated Press writers David Rising and Gir Moulsen in Berlin, Angela Charlton in Paris and Sierra Giles in Madrid contributed.
Follow the virus outbreak AP coverage at https://apnews.com/VirusOutbreak And https://apnews.com/UndersistancetheOutbreak